Information for "Favipiravir covid-19"
Jump to navigation
Jump to search
Basic information
| Display title | Favipiravir covid-19 |
| Redirects to | COVID-19 future or investigational therapies (info) |
| Default sort key | Favipiravir covid-19 |
| Page length (in bytes) | 58 |
| Namespace ID | 0 |
| Page ID | 331134 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Number of subpages of this page | 0 (0 redirects; 0 non-redirects) |
Page protection
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
Edit history
| Page creator | Gunnam (talk | contribs) |
| Date of page creation | 05:02, 24 June 2020 |
| Latest editor | Gunnam (talk | contribs) |
| Date of latest edit | 05:02, 24 June 2020 |
| Total number of edits | 1 |
| Total number of distinct authors | 1 |
| Recent number of edits (within past 30 days) | 0 |
| Recent number of distinct authors | 0 |